Khuong Chau Quang 4
4 · NextCure, Inc. · Filed Jun 28, 2021
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Khuong Chau Quang
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-24+14,250→ 14,250 totalExercise: $8.21Exp: 2031-06-23→ Common Stock (14,250 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.